Sartorius Stedim Biotech (OTCMKTS:SDMHF) Trading Down 5.9% – What’s Next?
by Scott Moore · The Cerbat GemSartorius Stedim Biotech S.A. (OTCMKTS:SDMHF – Get Free Report) shares were down 5.9% on Thursday . The company traded as low as $183.95 and last traded at $192.00. 244 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 2,401 shares. The stock had previously closed at $204.00.
Sartorius Stedim Biotech Price Performance
The company’s fifty day simple moving average is $199.42 and its 200 day simple moving average is $215.25.
About Sartorius Stedim Biotech
Sartorius Stedim Biotech SA (OTCMKTS: SDMHF) is a global provider of bioprocessing equipment and services for the biopharmaceutical industry. The company develops and manufactures technologies that support the development and production of vaccines, monoclonal antibodies, therapeutic proteins and cell‐ and gene‐based therapies. Its solutions address both upstream processes—such as cell cultivation and fermentation—and downstream processes, including filtration, centrifugation and chromatography.
Key product offerings include single‐use bioreactors and mixers, modular filtration assemblies, prepacked chromatography columns, and a wide range of cell culture media and buffer systems.